Skip to main content
Livermore
Livermore
ZHEN

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Citigroup Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−8,566−100.0%Sold outHolders
Q4 20258,566$290.1K<0.1%+8,542+35,591.7%AddedHolders
Q3 202524$619<0.1%−2,111−98.9%ReducedHolders
Q2 20252,135$17.1K<0.1%−19,627−90.2%ReducedHolders
Q1 202521,762$26.6K<0.1%−1,977−8.3%ReducedHolders
Q4 202423,739$37.5K<0.1%+1,172+5.2%AddedHolders
Q3 202422,567$45.4K<0.1%+7,251+47.3%AddedHolders
Q2 202415,316$46.7K<0.1%+10,056+191.2%AddedHolders
Q1 20245,260$47.2K<0.1%−33,935−86.6%ReducedHolders
Q4 202339,195$974.0K<0.1%−2,465−5.9%ReducedHolders
Q3 202341,660$692.4K<0.1%−2,896−6.5%ReducedHolders
Q2 202344,556$833.2K<0.1%−66,560−59.9%ReducedHolders
Q1 2023111,116$2.04M<0.1%+25,109+29.2%AddedHolders
Q4 202286,007$1.70M<0.1%+20,458+31.2%AddedHolders
Q3 202265,549$1.58M<0.1%+30,877+89.1%AddedHolders
Q2 202234,672$633.0K<0.1%+20,081+137.6%AddedHolders
Q1 202214,591$321.0K<0.1%−54,130−78.8%ReducedHolders
Q4 202168,721$2.52M<0.1%+64,423+1,498.9%AddedHolders
Q3 20214,298$133.0K<0.1%+1,584+58.4%AddedHolders
Q2 20212,714$86.0K<0.1%+1,351+99.1%AddedHolders
Q1 20211,363$30.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.